Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for ACUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
December 31, 2008 -28.50M
September 30, 2008 -10.33M
June 30, 2008 -0.822M
March 31, 2008 10.17M
December 31, 2007 23.74M
September 30, 2007 36.42M
June 30, 2007 50.35M
March 31, 2007 46.08M
December 31, 2006 58.45M
September 30, 2006 46.56M
June 30, 2006 59.18M
March 31, 2006 44.15M
December 31, 2005 57.42M
September 30, 2005 67.88M
June 30, 2005 60.58M
Date Value
March 31, 2005 76.57M
December 31, 2004 45.51M
September 30, 2004 50.83M
June 30, 2004 40.34M
March 31, 2004 47.70M
December 31, 2003 54.38M
September 30, 2003 -7.172M
June 30, 2003 -2.312M
March 31, 2003 1.951M
December 31, 2002 64.28M
September 30, 2002
June 30, 2002
March 31, 2002
December 31, 2001 11.51M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 597.21M
Corcept Therapeutics, Inc. 705.78M
Veru, Inc. 28.38M
Johnson & Johnson 84.97B
Eli Lilly & Co. 33.88B